Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation

Pharmazie

Volumn 63, Issue 8, 2008, Pages 580-584

  Shakeel, F ^a   Baboota, S ^b   Ahuja, A ^b   Ali, J ^b   Shafiq, S ^c  

^a Al Arab Medical Sciences University   (Libyan Arab Jamahiriya)

^b HAMDARD UNIVERSITY   (India)

^c ZYDUS RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; CERAMIDE; CHEMICAL COMPOUND; DIETHYLENE GLYCOL MONOETHYL ETHER; HYDROGEN; LIPID; OIL; PEGLICOL 5 OLEATE; POLYSORBATE 80; TRANSCUTOL P; TRIACETIN; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; EMULSION; ENERGY; EPIDERMIS; EXTRACTION; HISTOPATHOLOGY; HUMAN; HYDROGEN BOND; INFRARED SPECTROSCOPY; INTRACELLULAR TRANSPORT; LIPID BILAYER; MEASUREMENT; MICROPHOTOGRAPHY; NONHUMAN; RAT; SKIN; SKIN PERMEABILITY; STATISTICAL SIGNIFICANCE; THERMOGRAPHY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; EMULSIONS; NANOPARTICLES; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 50149116168     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8036     Document Type: Article

References (35)

1. Aqil M, Ali A, Sultana Y (2004) Matrix type transdermal drug delivery system of metoprolol tartrate: skin toxicity and in vivo characterization. Ethiop Pharm J 22: 53-60.
2. Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S (2007a) Design development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm 8: 315-332.
3. Baboota S, Alazaki A, Kohli K, Ali J, Dixit N, Shakeel F (2007b) Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine. PDA J Pharm Sci Technol 61: 276-285.
4. Babua RJ, Pandit JK (2005) Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. Int J Pharm 288: 325-334.
5. Clarys P, Alewaeters K, Jadoul A, Barel A, Manadas RO, Préat V (1998) In vitro percutaneous penetration through hairless rat skin: influence of temperature, vehicle and penetration enhancers. Eur J Pharm Biopharm 46: 279-283.
6. Cole L, Heard C (2007) Skin permeation enhancement potential of Aloe vera and a proposed mechanism of action based upon size exclusion and pull effect. Int J Pharm 333: 10-16.
7. Cotte M, Dumas P, Besnard M, Tchoreloff P, Walter P (2004) Synchrotron FT-IR microscopic study of chemical enhancers in transdermal drug delivery: example of fatty acids. J Control Release 97: 269-281.
8. Cullander PA, Guy RH (1991) Sites of iontophoretic current flow into the skin: identification and characterization with the vibrating probe electrode. J Invest Dermatol 97: 55-64.
9. Cumming KI, Winfield AJ (1994) In vitro evaluation of a series of sodium carboxylates as dermal penetration enhancers. Int J Pharm 108: 141-148.
10. Fang JY, Hung CF, Chiu HC, Wang JJ, Chan TF (2003) Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin. J Pharm Pharmacol 55: 593-601.
11. Gasco MR, Gallarate M, Pattarino F (1991) In vitro permeation of azelaic acid from viscosized microemulsions. Int J Pharm 69: 193-196.
12. Golden GM, Guzek DB, Harris RR, McKie JE, Potts RO (1986) Lipid thermotropic transition in human stratum corneum. J Invest Dermatol 86: 255-259.
13. Goodman M, Barry BW (1989) Action of penetration enhancers on human stratum corneum as assessed by differential scanning calorimetry. In: Bronaugh RL, Maibach HI (eds) Percutaneous absorption. Marcel Dekker, New York and Basel, 567-593.
14. Hori M, Satoh S, Maibach HI, Guy RH (1991) Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J Pharm Sci 80: 32-35.
15. Jain AK, Thomas NS, Panchagula R (2001) Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release 79: 93-101.
16. Krishnaiah YS, Al-Saidan SM, Jayaram B (2006) Effect of nerodilol, carvone and anethole on the in vitro transdermal delivery of selegiline hydrochloride. Pharmazie 61: 46-53.
17. Kriwet K, Muller-Goymann CC (1995) Diclofenac release from phospholipid drug systems and permeation through excised human stratum corneum. Int J Pharm 125: 231-242.
18. Ktistis G, Niopas I (1998) A study on the in-vitro percutaneous absorption of propranolol from disperse systems. J Pharm Pharmacol 50: 413-419.
19. Lee J, Lee Y, Kim J, Yoon M, Choi YK (2005a) Formulation of microemulsion systems for transdermal delivery of aceclofenac. Arch Pharm Res 28: 1097-1102.
20. Lee PJ, Langer R, Shastri VP (2005b) Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci 94: 912-917.
21. Monti D, Saettone MF, Giannaccini B, Galli-Angeli D (1995) Enhancement of transdermal penetration of dapiprazole through hairless mouse skin. J Control Release 33: 71-77.
22. Narishetty STK, Panchagnula R (2004) Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release 95: 367-379.
23. Pagano R, Thompson TE (1968) Spherical bilayer membranes: electrical and isotopic studies of ion permeability. J Mol Biol 38: 41-57.
24. Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P (2001) Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm 219: 95-105.
25. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M (2007a) Design and development of oral oil in water ramipril nanoemulsion formulation: In vitro and in vivo assessment. J Biomed Nanotech 3: 28-44.
26. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M (2007c) Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 66: 227-242.
27. Shafiq S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, Khar RK, Ali M (2007b) Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech 8: E28.
28. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S (2007) Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 8: E104.
29. Stott PW, Williams AC, Barry BW (2001) Mechanistic study into the enhanced transdermal permeation of a model β-blocker, propranolol, by fatty acids: a melting point depression effect. Int J Pharm 219: 161-176.
30. Trotta M (1999) Influence of phase transformation on indomethacin release from microemulsions. J Control Release 60: 399-405.
31. Vaddi HK, Ho PC, Chan SY (2002) Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform tnfrared spectroscopy and differential scanning calorimetry. J Pharm Sci 91: 1639-1651.
32. Xiong GL, Quan D, Maibach HI (1996) Effects of penetration enhacers on in vitro percutaneous absorption of low molecular weight heparin through human skin. J Control Release 42: 289-296
33. Yamane MA, Williams AC, Barry BW (1995) Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J Pharm Pharmacol 47: 978-989.
34. Yamazaki R, Kawai S, Mastsuzaki T (1997) Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors. Eur J Pharmacol 329: 181-187.
35. Zhao K, Singh J (1998) Mechanisms of percutaneous absorption of tamoxifen by terpenes: eugenol, D-limonene and menthone. J Control Release 55: 253-264.